Illumina Introduces TruSeq® Amplicon – Cancer Panel for MiSeq® System
March 7, 2012
SAN DIEGO-- Illumina (NASDAQ:ILMN) today introduced the TruSeq Amplicon - Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult samples such as formalin-fixed, paraffin embedded (FFPE) tumor samples. With the ability to detect mutations below 5% frequency, the TruSeq Amplicon assay [...]
Transgenomic Reports Fiscal Year 2011 Financial Results
March 7, 2012
Omaha, Neb. - Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for the year ended December 31, 2011 and provided a business update. “Transgenomic enjoyed a landmark year in 2011, with revenue growth quarter-over-quarter and year-over-year as well as an attention to expense management translating into positive modified EBITDA for both the fourth quarter and [...]
March 7, 2012
Chalfont St Giles, UK – GE Healthcare, a unit of GE (NYSE: GE) announced today it has reached an agreement to acquire Xcellerex, Inc. a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of [...]
March 7, 2012
Porvair Sciences has introduced a new range of high grade polypropylene flip cap centrifuge tubes that combine ease of use, chemical resistance and high speed tolerance. Designed for easy one-handed operation the secure leak proof flip cap lid on each centrifuge tube can also be unscrewed. Available in a range of standard sizes the dimensions [...]
Bio-Rad Introduces New Bio-Plex® Assays for Immunology and Cancer Biomarker Research
March 6, 2012
The Bio-Plex Pro Human Th17 Cytokine Panel and Bio-Plex Pro Human Cancer Biomarker Panel 1 deliver high-performance multiplex assays for immunology and cancer research, respectively. Hercules, CA - Bio-Rad Laboratories announced the launch of its new magnetic bead–based multiplex immunoassaysfor human T-helper type 17 (Th17) cytokines and cancer biomarkers. The Bio-Plex Pro™ immunoassays take advantage [...]
March 6, 2012
PARIS and LONDON,-- Biospace Lab S.A. and the Centre for Advanced Biomedical Imaging at University College London will collaborate on the development of novel real-time in vivo optical imaging applications and further development of the Biospace Lab PhotonIMAGER™ Optima pre-clinical imaging platform. The collaboration will bring together UCL experts in imaging, Dr Mark Lythgoe, and [...]
March 6, 2012
SAN FRANCISCO, CA IO Informatics, the leader in Semantic data integration and knowledge management for life sciences and healthcare, today announced a strategic partnership with Sage-N Research, Inc., the world leader in computational proteomics. This partnership includes the integration of Sage-N’s SORCERER™ Enterprise with the IO Informatics’ Sentient software suite. The combination of these technologies [...]
New IonBench LC Provides Safe Operation and Easy Transport of Stackable HPLC/UHPLC Systems
March 6, 2012
Evans Mills, NY and Gananoque, ON. Farhawk Marketing Servicesannounced today that three innovative new laboratory benches will be introduced to North America at Pittcon 2012 in Orlando, Florida, March 12-15th. The new Model BCHLC 4555, BCHLC4575 and BCHLC9075 electrical IonBench LC benches contribute significantly to lab safety and productivity. They are stable, secure platforms that [...]
March 6, 2012
Charlottesville, Va. and Bethesda, Md. – Lockheed Martin [NYSE: LMT] and ZyGEM Corp. Ltd. announced plans to release a version of their rapid DNA analysis platform that is designed to simplify and speed DNA analysis for human identity testing. Pre-production units of the platform will be released this summer to select customers in the forensic, [...]
Lab21 and ITOR unveil major leap forward in personalized cancer medicine
March 6, 2012
GREENVILLE, S.C. – The new Lab21 Clinical Genomics Center at ITOR will allow cancer patients in the Upstate to be among the first in the region to benefit from new technology that will allow patients to get real-time feedback and treatment plans tied to their cancer’s specific DNA signature. “Bringing this leading-edge technology to the [...]

